Cash Flow Coherus BioSciences, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
28.00
-238.00
-291.00
-287.00
135.00
92.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
55.00
-36.00
-79.00
42.00
-32.00
-113.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-20.00
-174.00
-241.00
-37.00
154.00
28.00
Cash Flow from Investing Activities
230.00
144.00
-166.00
-138.00
-14.00
-12.00
Cash Flow from Financing Activities
-186.00
69.00
54.00
51.00
223.00
89.00
Net Cash Inflow / Outflow
22.00
39.00
-353.00
-123.00
363.00
104.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Coherus BioSciences, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
28.507
-193.299
221.00
114.75%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
55.894
-18.401
73.00
403.76%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-20.44
-172.584
152.00
88.16%
Cash Flow from Investing Activities
230.321
-257.713
487.00
189.37%
Cash Flow from Financing Activities
-186.974
485.667
-671.00
-138.50%
Net Cash Inflow / Outflow
22.907
55.37
-33.00
-58.63%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 88.31% vs 27.47% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-20.44
-174.88
88.31%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
